NIH-funded research R03 grant

Understanding how serotonin in the placenta affects fetal brain development

Official title: Characterizing the Placenta-Brain Axis in Transgenic Mice Lacking Serotonin Transporter (SERT) in Trophoblast Cells

Funded at University of Missouri-Columbia · NIH-11056594 · Data updated 2026-11-12

This study is looking at how serotonin in the placenta might affect the development of a baby's brain, using special mice to see what happens when serotonin transport is disrupted, and it could help us understand how things like medications and chemicals in the environment might impact pregnancy.

Quick facts

Grant typeR03 grant
Study typeNIH-funded research
Funding institutionUniversity of Missouri-Columbia
NIH-funded
Lab location1 site (Columbia, United States)
Project startApril 9, 2025
Project endMarch 31, 2027
Funding year2025
Award (this year)$156,500
NIH project number1R03HD114968-01A1
Project IDNIH-11056594 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are pregnant individuals or those planning to become pregnant, particularly those with concerns about serotonin-related conditions.

Less likely to help

Patients who are not pregnant or do not plan to become pregnant may not receive any benefit from this research.

What this research studies

This research investigates the role of serotonin in the placenta and its potential effects on fetal brain development. By studying transgenic mice that lack the serotonin transporter in trophoblast cells, researchers aim to uncover how serotonin influences placental function and fetal health. The study will explore the mechanisms by which serotonin is transported and its paracrine actions within the placenta, particularly focusing on how disruptions in serotonin levels may lead to complications in fetal development. This research could provide insights into the impact of external factors, such as medications and environmental chemicals, on pregnancy outcomes.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding of how placental serotonin affects fetal brain development, potentially informing better prenatal care and interventions.

How similar studies have gone: While the specific approach of this research is novel, previous studies have shown that understanding the placenta's role in fetal development can lead to significant advancements in maternal and child health.

Where this research is happening

  • University of Missouri-Columbia
    Columbia, United States
    Active

Researchers

  • Principal investigator: Rosenfeld, Cheryl Susan — University of Missouri-Columbia
  • Study coordinator: Rosenfeld, Cheryl Susan

Related research

Other NIH-funded projects on the same topics.

  • Boosting immune response to fight cancer

    This study is exploring a new way to help your immune system better fight cancer by tweaking certain cells in your body, and it aims to improve treatment for people with advanced cancer.

    NIH research University of Missouri-Columbia · Columbia, United States · NIH-9868156

  • Interface between immune cells and scarring in the eye

    This grant looks at how immune cells influence scar formation in the cornea after injury and how this affects vision.

    NIH research University of Missouri-Columbia · Columbia, United States · NIH-11609392

  • Understanding cell-cleanup problems in C9ORF72-related ALS/FTD

    Researchers are studying why the body's cell-cleanup systems fail in a genetic form of ALS/FTD to pave the way for better treatments.

    NIH research University of Missouri-Columbia · Columbia, United States · NIH-11606636

  • Molecular clues to endometriosis-related infertility

    This grant explores how molecular changes in endometriosis contribute to infertility, with the aim of finding better ways to diagnose and treat the condition.

    NIH research University of Missouri-Columbia · Columbia, United States · NIH-11595518

  • A universal Shigella vaccine using SAVE to protect people of all ages

    A new vaccine approach called SAVE aims to prevent Shigella-related dysentery across all ages, including children and adults, by targeting conserved bacterial components.

    NIH research University of Missouri-Columbia · Columbia, United States · NIH-11464403

  • Biomarkers that predict osteoarthritis risk in people at higher risk

    A long-term study will look for protein markers in body fluids that could predict who will develop knee osteoarthritis before symptoms appear.

    NIH research University of Missouri-Columbia · Columbia, United States · NIH-11461903

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.